Fibrinogen in the offspring of men with premature coronary artery disease

L S Rallidis1, N H Papageorgakis, A A Megalou

  • 1Department of Cardiology, Evangelismos Hospital, Greece.

European Heart Journal
|December 1, 1995
PubMed

Insights

Children of men who had heart attacks before age 55 have higher fibrinogen levels, a risk factor for heart disease. Elevated fibrinogen may indicate increased coronary artery disease risk in offspring, even with normal cholesterol.

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Biochemistry

Background:

  • Premature coronary artery disease (CAD) in fathers is a known risk factor for CAD in offspring.
  • Elevated plasma fibrinogen levels are associated with an increased risk of thrombotic events and CAD.

Purpose of the Study:

  • To investigate whether offspring of middle-aged men with myocardial infarction (MI) exhibit higher fibrinogen levels compared to controls.
  • To assess other lipid parameters in relation to familial history of premature CAD.

Main Methods:

  • A cohort of 176 young subjects was divided into two groups: offspring of fathers with premature MI (n=100) and a matched control group (n=76).
  • Plasma levels of fibrinogen, total cholesterol, triglycerides, HDL-C, LDL-C, ApoA-1, ApoB, and Lp(a) were measured.
  • Statistical analysis was performed to compare parameters between groups.

Main Results:

  • Offspring of fathers with premature MI (Group A) showed significantly higher fibrinogen levels (304.1 ± 60 mg/dL) compared to the control group (274 ± 53 mg/dL, P < 0.001).
  • Group A also had significantly higher levels of total cholesterol, LDL-C, ApoB, and Lp(a).
  • Elevated fibrinogen was observed even in offspring with normal lipid profiles.

Conclusions:

  • Higher plasma fibrinogen levels in offspring of men with premature MI may contribute to their predisposition to CAD.
  • Fibrinogen, with its significant genetic component, could serve as a valuable biomarker for identifying high-risk children for CAD, particularly those without lipid abnormalities.

Related Concept Videos

Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...